@article{e830adc5ec944f12b273236c371c4332,
title = "Editorial",
author = "Charles Oo and Tsai, \{Jui Chen\} and Kao, \{H. Danny\}",
note = "Funding Information: H. Danny Kao received his B.Sc. in Pharmacy from the National Taiwan University, M.S. from St. John's University, a Ph.D. from the University of Kentucky, and J.D. from the Touro College, New York. He is a registered patent attorney, a member of the Regulatory Working Group of Cross Company Abuse Liability Consortium, and has been awarded a fellowship from the Pharmaceutical Research and Manufacturers of America. He has an expertise in opioid drug formulations and delivery systems, and has more than 20 issued and pending patents. He currently works as the chief IP counsel and senior vice president of Relmada Therapeutics Inc, and has previously worked for Endo and DuPont Pharma. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2015",
doi = "10.1016/j.drudis.2015.03.013",
language = "English",
volume = "20",
pages = "645--647",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "6",
}